Hemophilia B - 30 Studies Found
Active, not recruiting |
: Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B : Hemophilia B : 2012-08-27 : Biological: AskBio009 Single dose IV injection Other |
Completed |
: Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B : Hemophilia B : 2007-06-07 : Drug: BeneFIX (coagulation factor IX (recombinant)) BeneFIX will be administered according to physician' |
Recruiting |
: Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B : Hemophilia B : 2009-09-16 :
|
Completed |
: Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX) : Hemophilia B : 2005-08-30 : Drug: human coagulation Factor IX Other Name: Nonafact |
Terminated |
: Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B : Hemophilia B : 2004-01-26 : Genetic: Adeno-Associated Viral with Human Factor IX |
Completed |
: Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients : Hemophilia B : 2005-10-19 :
|
Terminated |
: Hemophilia B Gene Therapy With AAV8 Vector : Hemophilia B : 2012-06-12 : Biological: AAV8-hFIX19 One-time IV vector administration. |
Recruiting |
: A Gene Therapy Study for Hemophilia B : Hemophilia B : 2015-06-18 : Genetic: SPK-9001 A novel, bioengineered adeno-associated viral vector carrying human factor IX variant |
Active, not recruiting |
: LTFU for Gene Transfer Subjects With Hemophilia B : Hemophilia B : 2007-08-10 |
Completed |
: BeneFIX Drug Use Results Survey [All-Case Surveillance] : Hemophilia B : 2010-06-28 : Drug: Nonacog Alfa (Genetical Recombination) Patients with |